本帖最后由 于 2007-05-09 22:34:00 编辑
Occurrence of Endometrial Glandular Dysplasia Precedes
Uterine Papillary Serous Carcinoma
Wenxin Zheng, M.D., Sharon X. Liang, M.D., Ph.D., Xiaofang Yi, M.D., Ph.D.,
E. Cagnur Ulukus, M.D., John R. Davis, M.D., and Setsuko K. Chambers, M.D.
Int J Gynecol Pathol, Vol. 26, No. 1, January 2007
Summary: Endometrial glandular dysplasia (EmGD) is a newly defined entity that is commonly and specifically associated with serous endometrial intraepithelial carcinoma and uterine papillary serous carcinoma (UPSC). Endometrial glandular dysplasia has been proposed as a true precancerous lesion of UPSC based on our recent studies showing morphological and molecular linkages between these 2 lesions. The present report is to examine if EmGD occurs before UPSC development and to define the period from the occurrence of EmGD to a full-blown UPSC by studying their clinicopathologic features in a retrospective setting. A total of 250 UPSC and 258 benign cases were used as initial study source. To identify if EmGD existed before the development of UPSC, we blindly reviewed all available endometrial biopsies from a period of 3 months or earlier before hysterectomies. These included an available pool of 27 biopsy specimens from UPSC group and 29 samples from benign control group. Any endometrial abnormalities, which morphologically qualified as EmGD as defined previously in preceding biopsies were recorded. Among all endometrial biopsies before hysterectomies, we morphologically identified a total of 10 EmGD cases; 9 (33%) of 27 were from UPSC group and 1 (3.5%) of 29 were from benign control group. All 10 morphologically diagnosed EmGD cases showed a high p53 staining score (Q5) except 1 noncontributory from UPSC group and 1 from the benign control group with a score of 0. A high MIB-1 index score was seen in all EmGD cases, whereas low index was found in morphologically benign biopsies. The main purpose of this study is to report these retrospectively identified EmGD cases. The period from identifying EmGD to the presence of either a serous endometrial intraepithelial carcinoma or a full-blown UPSC ranged from 16 to 98 months with an average of 33 months.We conclude that occurrence of EmGD precedes the development of UPSC. The findings support our recently proposed UPSC development model, in which EmGD is likely to be a precursor lesion of UPSC. Further studies are needed to address issues in regard to molecular and cellular mechanisms, reversibility, risk of UPSC development, and clinical management of EmGD. Key Words: Endometrial glandular dysplasia (EmGD)—Serous endometrial intraepithelial carcinoma—Uterine papillary serous carcinoma—Endometrial cancer precursors.
很抱歉由于版权问题,不能引用全文。以下各图均引自此文,谨向郑文新老师(Wenxin Zheng, M.D.)致谢!感谢wangzhen_01提供资料!
zhjjwf 译:
子宫内膜腺体不典型增生先于子宫浆液性乳头状癌的出现
摘要:子宫内膜腺体不典型增生(EmGD)是一个新的概念体系,它通常与浆液性子宫内膜上皮内癌和子宫内膜浆液性乳头状癌(UPSC)有特定的联系.有人建议将子宫内膜腺体不典型增生看作UPSC的一种真正的癌前病变,根据我们最近的研究显示两者在形态学和分子水平有关联。本研究应用回顾性研究方式,通过观察它们的临床病理特征,以检测是否EmGD出现在UPSC发展之前,并界定从EmGD的出现到充分发展为UPSC的时期。250例UPSC 和258例良性病例被用于本次研究。为了鉴定是否EmGD 出现在UPSC 之前,我们重新观察了所有可得到的子宫切除前3个月或更早的子宫内膜活检标本。这包括来自UPSC的27例活检标本和29例良性对照组的标本。那些在子宫内膜形态学上异常,与原来活检时的诊断一致且符合EmGD的病例,将被记录下来。在所有子宫切除前的内膜活检标本中,我们在形态学上确诊为EmGD的共10例;包括27例UPSC组中的9例(33%),29例良性对照组中的1例。除1例来自UPSC组未进行检测和1例来自良性对照组的得分为0分外,10例形态学上诊断为EmGD的病例均显示p53染色的高得分(5分)。
所有EmGD病例均表现为高MIB-1指数,但形态上表现为良性的病例则为低的MIB-1指数。本研究的主要目的是回顾性地研究这些确诊为EmGD的病例。从确诊为EmGD到出现子宫内膜上皮内浆液性癌或完全发展为UPSC的时间为16到98个月,平均为33个月。我们得出结论,EmGD的出现早于UPSC的发生。这一发现支持了我们最近提出的UPSC发展模型建议,这一模型认为EmGD很可能是UPSC的癌前病变。更深入的研究需要集中探讨其分子及细胞学机制、可逆性和UPSC发展的危害和EmGD的临床处理。
关键词:子宫内膜腺体不典型增生(EmGD) 子宫内膜上皮内浆液性癌 子宫内膜浆液性乳头状癌 子宫内膜癌前病变
Occurrence of Endometrial Glandular Dysplasia Precedes
Uterine Papillary Serous Carcinoma
Wenxin Zheng, M.D., Sharon X. Liang, M.D., Ph.D., Xiaofang Yi, M.D., Ph.D.,
E. Cagnur Ulukus, M.D., John R. Davis, M.D., and Setsuko K. Chambers, M.D.
Int J Gynecol Pathol, Vol. 26, No. 1, January 2007
Summary: Endometrial glandular dysplasia (EmGD) is a newly defined entity that is commonly and specifically associated with serous endometrial intraepithelial carcinoma and uterine papillary serous carcinoma (UPSC). Endometrial glandular dysplasia has been proposed as a true precancerous lesion of UPSC based on our recent studies showing morphological and molecular linkages between these 2 lesions. The present report is to examine if EmGD occurs before UPSC development and to define the period from the occurrence of EmGD to a full-blown UPSC by studying their clinicopathologic features in a retrospective setting. A total of 250 UPSC and 258 benign cases were used as initial study source. To identify if EmGD existed before the development of UPSC, we blindly reviewed all available endometrial biopsies from a period of 3 months or earlier before hysterectomies. These included an available pool of 27 biopsy specimens from UPSC group and 29 samples from benign control group. Any endometrial abnormalities, which morphologically qualified as EmGD as defined previously in preceding biopsies were recorded. Among all endometrial biopsies before hysterectomies, we morphologically identified a total of 10 EmGD cases; 9 (33%) of 27 were from UPSC group and 1 (3.5%) of 29 were from benign control group. All 10 morphologically diagnosed EmGD cases showed a high p53 staining score (Q5) except 1 noncontributory from UPSC group and 1 from the benign control group with a score of 0. A high MIB-1 index score was seen in all EmGD cases, whereas low index was found in morphologically benign biopsies. The main purpose of this study is to report these retrospectively identified EmGD cases. The period from identifying EmGD to the presence of either a serous endometrial intraepithelial carcinoma or a full-blown UPSC ranged from 16 to 98 months with an average of 33 months.We conclude that occurrence of EmGD precedes the development of UPSC. The findings support our recently proposed UPSC development model, in which EmGD is likely to be a precursor lesion of UPSC. Further studies are needed to address issues in regard to molecular and cellular mechanisms, reversibility, risk of UPSC development, and clinical management of EmGD. Key Words: Endometrial glandular dysplasia (EmGD)—Serous endometrial intraepithelial carcinoma—Uterine papillary serous carcinoma—Endometrial cancer precursors.
很抱歉由于版权问题,不能引用全文。以下各图均引自此文,谨向郑文新老师(Wenxin Zheng, M.D.)致谢!感谢wangzhen_01提供资料!
zhjjwf 译:
子宫内膜腺体不典型增生先于子宫浆液性乳头状癌的出现
摘要:子宫内膜腺体不典型增生(EmGD)是一个新的概念体系,它通常与浆液性子宫内膜上皮内癌和子宫内膜浆液性乳头状癌(UPSC)有特定的联系.有人建议将子宫内膜腺体不典型增生看作UPSC的一种真正的癌前病变,根据我们最近的研究显示两者在形态学和分子水平有关联。本研究应用回顾性研究方式,通过观察它们的临床病理特征,以检测是否EmGD出现在UPSC发展之前,并界定从EmGD的出现到充分发展为UPSC的时期。250例UPSC 和258例良性病例被用于本次研究。为了鉴定是否EmGD 出现在UPSC 之前,我们重新观察了所有可得到的子宫切除前3个月或更早的子宫内膜活检标本。这包括来自UPSC的27例活检标本和29例良性对照组的标本。那些在子宫内膜形态学上异常,与原来活检时的诊断一致且符合EmGD的病例,将被记录下来。在所有子宫切除前的内膜活检标本中,我们在形态学上确诊为EmGD的共10例;包括27例UPSC组中的9例(33%),29例良性对照组中的1例。除1例来自UPSC组未进行检测和1例来自良性对照组的得分为0分外,10例形态学上诊断为EmGD的病例均显示p53染色的高得分(5分)。
所有EmGD病例均表现为高MIB-1指数,但形态上表现为良性的病例则为低的MIB-1指数。本研究的主要目的是回顾性地研究这些确诊为EmGD的病例。从确诊为EmGD到出现子宫内膜上皮内浆液性癌或完全发展为UPSC的时间为16到98个月,平均为33个月。我们得出结论,EmGD的出现早于UPSC的发生。这一发现支持了我们最近提出的UPSC发展模型建议,这一模型认为EmGD很可能是UPSC的癌前病变。更深入的研究需要集中探讨其分子及细胞学机制、可逆性和UPSC发展的危害和EmGD的临床处理。
关键词:子宫内膜腺体不典型增生(EmGD) 子宫内膜上皮内浆液性癌 子宫内膜浆液性乳头状癌 子宫内膜癌前病变